1.
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
by His, Mathilde
European journal of epidemiology, 2014-01-01, Vol.29 (2), p.119-132
2.
Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia
by Hooper, Amanda J
The journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.E1484-E1490
3.
Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip
by Talmud, Philippa J
American journal of human genetics, 2009-11-13, Vol.85 (5), p.628-642
4.
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
by O'Donnell, Martin J, Dr
The Lancet (British edition), 2016, Vol.388 (10046), p.761-775
5.
Consumption of Fructose and High Fructose Corn Syrup Increase Postprandial Triglycerides, LDL-Cholesterol, and Apolipoprotein-B in Young Men and Women
by Stanhope, Kimber L
The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.E1596-E1605
6.
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
by Soutschek, Jürgen
Nature, 2004-11-11, Vol.432 (7014), p.173-178
7.
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
by Bril, Fernando
The journal of clinical endocrinology and metabolism, 2016-02, Vol.101 (2), p.644-652
8.
Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD
by Shojaee-Moradie, F
The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.4219-4228
9.
Mutations in the ANGPTL3 Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical Characterization
by Minicocci, Ilenia
The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.E1266-E1275
10.
HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab
by Raterman, Hennie G
Annals of the rheumatic diseases, 2013-04, Vol.72 (4), p.560-565
11.
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
by Schwartz, Gregory G., MD, PhD
The American heart journal, 2014, Vol.168 (5), p.682-689.e1
12.
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
by Walldius, Göran
The Lancet (British edition), 2001-12-15, Vol.358 (9298), p.2026-2033
13.
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis
by van Halm, V P
Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.184-188
14.
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
by Borén, Jan
Nature (London), 2002-06-13, Vol.417 (6890), p.750-754
15.
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
by Ooi, Esther M. M
The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.E1568-E1576
16.
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular...
by Robinson, Jennifer G., MD, MPH
The American journal of cardiology, 2012, Vol.110 (10), p.1468-1476
17.
The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response
by Ooi, Teik Chye
The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3452-3460
18.
Lipids and HCV
by Bassendine, M. F
Seminars in immunopathology, 2012-10-31, Vol.35 (1), p.87-100
19.
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)
by Mosca, Lori, MD, MPH, PhD
The American journal of cardiology, 2016, Vol.119 (3), p.397-403
20.
A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study
by Valkenburg, Olivier
The journal of clinical endocrinology and metabolism, 2008-02, Vol.93 (2), p.470-476
